A concise review on hPXR ligand-recognizing residues and structure-based strategies to alleviate hPXR transactivation

Tao Liu1, James P Beck1, Junliang Hao1

  • 1Discovery Chemistry Research & Technologies, Eli Lilly and Company, Lilly Biotechnology Center 10290 Campus Point Drive San Diego CA 92121 USA liu_tao2@lilly.com.